Skip to main content

Zoek op

Reset all filters
137 Result(s)
Sorteren op

Diabetes

Diabetes

Learn more about diabetes and how Boehringer Ingelheim is working to research and develop newer, innovative diabetes medications to improve patients lives.
Geestelijke stoornissen

Geestelijke stoornissen

Boehringer Ingelheim has a range of different compounds in development for Central Nervous System (CNS) diseases, some in advanced clinical phases.
Huidziekten

Huidziekten

We discover and develop breakthrough therapies that can be used to prevent, treat and repair many inflammatory and fibrotic diseases.
Stofwisseling

Stofwisseling

Metabolic Diseases About 425 million adult people in the world are living with diabetes, with Type 2 diabetes accounting for 90 – 95 percent of all cases
Therapeutica

Therapeutica

We provide a disciplined scientific approach to the global discovery, development and delivery of therapeutics for all relevant animal species.
Hart- en vaatziekten

Hart- en vaatziekten

Note: This webpage hosts content for general public as well as for healthcare professional and journalists & media professionals.
Sclerodermie

Sclerodermie

Systemic sclerosis is a complex rare disease with a variable course. It presents with a range of symptoms involving several different organs